The Oklahoma Rheumatic Disease Research Core Center in Human Genetics (ORDRCCHG) will build on the strengths of the Oklahoma Medical Research Foundation Arthritis and Immunology program and expand this leadership to apply cutting edge genetic approaches to complex rheumatic disease problems. By melding human geneticists, developmental immunologists, immunogeneticists, theoretical physicists, molecular biologists, and inflammation experts with pediatric and adult clinical investigators (spanning the clinical disciplines of rheumatology, dermatology, hematology/oncology, endocrinology, allergy/immunology, genetics and cardiology), this core center will enhance a multidisciplinary approach to rheumatic disease research. The emphasis of this Core Center will apply the resources and infrastructure being developed in human genetics for systemic rheumatic diseases. Now that substantial progress has been made in the identification of key genetic susceptibility regions in SLE, this core center will provide key support to entice outside investigators into the characterization of the key genes located within these regions. In addition, parallel, but experience refined, approaches can be applied to other systemic autoimmune rheumatic diseases, such as scleroderma, Wegener's granulomatosis, anti-phospholipid syndrome, thrombotic thrombocytopenic purpura (TTP) and others. These efforts will be enhanced by the key scientific cores for 1) High throughput SNP genotyping, association testing, and expression, 2) Data analysis and 3) Sample procurement and management. Coordinated efforts by the Administrative Core will also streamline regulatory requirements through support for human subjects training, IRB applications, HIPPA compliance, grants management, publication support and data management will greatly enhance research efforts, especially for junior investigators or basic scientists branching into rheumatic disease research. A comprehensive and multidisciplinary Enhancement Program will provide ongoing multidisciplinary training through seminars, visiting professorships, workshops and mentoring program will enhance the research and educational environment in Oklahoma. The long-term goals of the ORDRCCHG are to provide key insights to the etiology and pathogenesis of autoimmune systemic rheumatic diseases through implementation of a multidisciplinary approach among a cadre of internationally recognized investigators.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR053483-05
Application #
8120817
Study Section
Special Emphasis Panel (ZAR1-KM-K (M1))
Program Officer
Witter, James
Project Start
2007-09-01
Project End
2012-08-31
Budget Start
2011-09-01
Budget End
2012-08-31
Support Year
5
Fiscal Year
2011
Total Cost
$560,720
Indirect Cost
Name
Oklahoma Medical Research Foundation
Department
Type
DUNS #
077333797
City
Oklahoma City
State
OK
Country
United States
Zip Code
73104
Merrill, Joan T; Immermann, Fred; Whitley, Maryann et al. (2017) The Biomarkers of Lupus Disease Study: A Bold Approach May Mitigate Interference of Background Immunosuppressants in Clinical Trials. Arthritis Rheumatol 69:1257-1266
Young, Kendra A; Munroe, Melissa E; Guthridge, Joel M et al. (2017) Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Ann Rheum Dis 76:153-158
Zhao, Jian; Ma, Jianyang; Deng, Yun et al. (2017) A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet 49:433-437
Hinks, A; Bowes, J; Cobb, J et al. (2017) Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. Ann Rheum Dis 76:765-772
Shiboski, Caroline H; Shiboski, Stephen C; Seror, Raphaèle et al. (2017) 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol 69:35-45
Munroe, Melissa E; Pezant, Nathan; Brown, Michael A et al. (2017) Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis. PLoS One 12:e0171193
Li, He; Reksten, Tove Ragna; Ice, John A et al. (2017) Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons. PLoS Genet 13:e1006820
Aberle, Teresa; Bourn, Rebecka L; Munroe, Melissa E et al. (2017) Clinical and Serologic Features in Patients With Incomplete Lupus Classification Versus Systemic Lupus Erythematosus Patients and Controls. Arthritis Care Res (Hoboken) 69:1780-1788
Talsania, Mitali; Scofield, Robert Hal (2017) Menopause and Rheumatic Disease. Rheum Dis Clin North Am 43:287-302
Munroe, Melissa E; Vista, Evan S; Merrill, Joan T et al. (2017) Pathways of impending disease flare in African-American systemic lupus erythematosus patients. J Autoimmun 78:70-78

Showing the most recent 10 out of 265 publications